# Nexus NeuroTech

Nexus NeuroTech is an Asset Manager based in New York, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 2022
- **Assets under management:** Undisclosed
- **Website:** nexusneurotech.com

## Regulatory record

- **CRD number:** 328851
- **SEC file number:** 802-129113
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/328851

## About

NEXUS NEUROTECH, LLC is an SEC-registered investment adviser since 2023. It is registered with the SEC.

## Sectors

- Digital Health
- AI/ML
- Healthcare Services

## People

- Alex Tarrand — Chief Executive Officer
- Sourav Sengupta — Chief Investment Officer

## Questions

### Which sectors does Nexus NeuroTech explicitly avoid?

Nexus NeuroTech does not invest in general digital health, traditional biopharma, medical devices outside neural interfaces, or pure software-as-a-service businesses. The firm's mandate excludes non-neurological therapeutic areas, wellness apps without regulatory clearance pathways, and hardware companies without brain-interface or neuromodulation core technology.

### How does Nexus NeuroTech source its deals?

The firm sources primarily through academic neuroscience hubs, neural-engineering conferences, and relationships with university technology-transfer offices. Co-founders Tarrand and Sengupta have positioned the firm as a domain-specialist partner to neurotech founders, which generates proprietary flow distinct from auction processes run by generalist VCs.

## Related profiles

- [Palm View Investments](https://altss.com/profile/palm-view-investments)
- [EN+ WEALTH](https://altss.com/profile/en-wealth)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/nexus-neurotech-llc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology